As discussed earlier, IRAK1 inhibitors (IRAK1i) were highly effective at suppressing R-RT in live p53 mutant zebrafish and human cancer cell lines assayed in vitro or as mouse xenografts in vivo (47). This evidence concerns the gene TP53 and cancer.